Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes – A multicenter retrospective study

PURPOSE: To report the initial experience of managing treatment-resistant and treatment-naïve eyes with polypoidal choroidal vasculopathy (PCV) by using brolucizumab 6 mg. METHODS: This was a retrospective multicentric series of all consecutive eyes with PCV treated with brolucizumab. Treatment resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Debdulal, Maiti, Aniruddha, Sengupta, Sabyasachi, Mondal, Soumen, Nandi, Krishnendu, Chakraborty, Somnath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Special Focus, Retina, Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240502/
https://www.ncbi.nlm.nih.gov/pubmed/35326038
http://dx.doi.org/10.4103/ijo.IJO_2513_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240502/
https://www.ncbi.nlm.nih.gov/pubmed/35326038
http://dx.doi.org/10.4103/ijo.IJO_2513_21

Ejemplares similares